Will percutaneous valves replace the surgical valves: Another one bites the dust?

Trans-cutaneous valve implantation (TAVI) has witnessed rapid evolution in terms of technical design, efficacy, and safety outcomes. This has led to expanding indications of TAVI from inoperable to high surgical to now even lower surgical risk patients. However, its cost and applicability only in el...

Descripción completa

Detalles Bibliográficos
Autor principal: Mishra, Sundeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911450/
https://www.ncbi.nlm.nih.gov/pubmed/27316471
http://dx.doi.org/10.1016/j.ihj.2016.04.019
_version_ 1782438130193793024
author Mishra, Sundeep
author_facet Mishra, Sundeep
author_sort Mishra, Sundeep
collection PubMed
description Trans-cutaneous valve implantation (TAVI) has witnessed rapid evolution in terms of technical design, efficacy, and safety outcomes. This has led to expanding indications of TAVI from inoperable to high surgical to now even lower surgical risk patients. However, its cost and applicability only in elderly patients with degenerated valves is a cause of concern limiting the use of this technology. Further evolution may lead to its application in lower risk essentially younger patients with broader etiologic sub-groups.
format Online
Article
Text
id pubmed-4911450
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-49114502017-05-01 Will percutaneous valves replace the surgical valves: Another one bites the dust? Mishra, Sundeep Indian Heart J Editorial Trans-cutaneous valve implantation (TAVI) has witnessed rapid evolution in terms of technical design, efficacy, and safety outcomes. This has led to expanding indications of TAVI from inoperable to high surgical to now even lower surgical risk patients. However, its cost and applicability only in elderly patients with degenerated valves is a cause of concern limiting the use of this technology. Further evolution may lead to its application in lower risk essentially younger patients with broader etiologic sub-groups. Elsevier 2016 2016-05-06 /pmc/articles/PMC4911450/ /pubmed/27316471 http://dx.doi.org/10.1016/j.ihj.2016.04.019 Text en © 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Mishra, Sundeep
Will percutaneous valves replace the surgical valves: Another one bites the dust?
title Will percutaneous valves replace the surgical valves: Another one bites the dust?
title_full Will percutaneous valves replace the surgical valves: Another one bites the dust?
title_fullStr Will percutaneous valves replace the surgical valves: Another one bites the dust?
title_full_unstemmed Will percutaneous valves replace the surgical valves: Another one bites the dust?
title_short Will percutaneous valves replace the surgical valves: Another one bites the dust?
title_sort will percutaneous valves replace the surgical valves: another one bites the dust?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911450/
https://www.ncbi.nlm.nih.gov/pubmed/27316471
http://dx.doi.org/10.1016/j.ihj.2016.04.019
work_keys_str_mv AT mishrasundeep willpercutaneousvalvesreplacethesurgicalvalvesanotheronebitesthedust

Ejemplares similares